These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 1654986

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Greater enhancement of chemosensitivity by caffeine in high-p185neu-expressing human non-small-cell lung cancer cell lines.
    Tsai CM, Perng RP, Chen MH, Jan YH, Hung MC, Ku TY, Chang KT.
    J Natl Cancer Inst; 1994 Jul 06; 86(13):1018-20. PubMed ID: 7911844
    [No Abstract] [Full Text] [Related]

  • 24. Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
    Mellon JK, Cook S, Chambers P, Neal DE.
    Br J Cancer; 1996 Mar 06; 73(5):654-8. PubMed ID: 8605103
    [Abstract] [Full Text] [Related]

  • 25. The receptor for epidermal growth factor is present in human fetal kidney, liver and lung.
    Nexø E, Kryger-Baggesen N.
    Regul Pept; 1989 Aug 06; 26(1):1-8. PubMed ID: 2813853
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.
    Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM.
    Radiology; 2005 Oct 06; 237(1):342-7. PubMed ID: 16183941
    [Abstract] [Full Text] [Related]

  • 28. Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy.
    Tsakiridis T, Cutz JC, Singh G, Hirte H, Okawara G, Corbett T, Sur R, Cai W, Whelan T, Wright JR.
    J Thorac Oncol; 2008 Jul 06; 3(7):716-22. PubMed ID: 18594316
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B.
    Wakata K, Tsuchiya T, Tomoshige K, Takagi K, Yamasaki N, Matsumoto K, Miyazaki T, Nanashima A, Whitsett JA, Maeda Y, Nagayasu T.
    BMJ Open; 2015 Jul 29; 5(7):e008366. PubMed ID: 26224019
    [Abstract] [Full Text] [Related]

  • 31. A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
    Christensen ME, Engbaek F, Therkildsen MH, Bretlau P, Nexø E.
    Br J Cancer; 1995 Dec 29; 72(6):1487-93. PubMed ID: 8519664
    [Abstract] [Full Text] [Related]

  • 32. Immunoenzymetric assay of epidermal growth factor receptor. Application to breast tumor samples.
    Grimaux M, Lainé-Bidron C, Magdelénat H.
    Tumour Biol; 1989 Dec 29; 10(4):215-24. PubMed ID: 2675297
    [Abstract] [Full Text] [Related]

  • 33. MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.
    Guddo F, Giatromanolaki A, Koukourakis MI, Reina C, Vignola AM, Chlouverakis G, Hilkens J, Gatter KC, Harris AL, Bonsignore G.
    J Clin Pathol; 1998 Sep 29; 51(9):667-71. PubMed ID: 9930070
    [Abstract] [Full Text] [Related]

  • 34. High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non-squamous non-small-cell lung cancer.
    Stone E, Allen HA, Saghaie T, Abbott A, Daniel R, Mead RS, Kohonen-Corish M, Plit M, Morgan L.
    Intern Med J; 2014 Dec 29; 44(12a):1188-92. PubMed ID: 25228365
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
    Garcia de Palazzo IE, Adams GP, Sundareshan P, Wong AJ, Testa JR, Bigner DD, Weiner LM.
    Cancer Res; 1993 Jul 15; 53(14):3217-20. PubMed ID: 8391918
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model.
    Zhang X, Nakajima T, Kim M, Yamaguchi A, Lamid-Ochir O, Nguyen-Thu H, Bhattarai A, Hanaoka H, Tsushima Y.
    PLoS One; 2018 Jul 15; 13(6):e0198224. PubMed ID: 29856819
    [Abstract] [Full Text] [Related]

  • 40. Antigens, receptors and dominant oncogenes and the prognosis of non-small cell lung cancer.
    Stahel RA.
    Lung Cancer; 1994 Nov 15; 11 Suppl 3():S31-8. PubMed ID: 7704510
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.